Cladribine regimen for treating multiple sclerosis | Patent Number 08377903

US 08377903 B2
Application Number12766173
Publication NumberUS 20100203017 A1
Pendency2 years, 10 months, 3 days
Filled DateApr 23, 2010
Priority DateDec 22, 2004
Publication DateAug 12, 2010
Expiration DateDec 22, 2024
Inventor/ApplicantsMaria Lopez-Bresnahan
Arnaud Ythier
Alain Munafo
Giampiero De Luca
ExaminesBALLARD, KIMBERLY
Art Unit1649
Technology Center1600
Assignments
Merck Serono Sa
Current
Merck Serono SaMerck & Co. Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.